Sanofi (EPA:SAN)
81.45
+0.85 (1.05%)
Dec 16, 2025, 1:15 PM CET
Sanofi Employees
Sanofi had 82,878 employees as of December 31, 2024. The number of employees decreased by 3,210 or -3.73% compared to the previous year.
Employees
82,878
Change (1Y)
-3,210
Growth (1Y)
-3.73%
Revenue / Employee
€554,200
Profits / Employee
€109,957
Market Cap
98.07B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 82,878 | -3,210 | -3.73% |
| Dec 31, 2023 | 86,088 | -5,485 | -5.99% |
| Dec 31, 2022 | 91,573 | -3,869 | -4.05% |
| Dec 31, 2021 | 95,442 | -3,970 | -3.99% |
| Dec 31, 2020 | 99,412 | -997 | -0.99% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| EssilorLuxottica Société anonyme | 153,498 |
| emeis Société anonyme | 83,494 |
| Eurofins Scientific SE | 62,696 |
| Clariane SE | 61,798 |
| Ramsay Générale de Santé | 40,494 |
| bioMérieux | 14,754 |
| Sartorius Stedim Biotech | 9,901 |
| Virbac | 6,365 |
Sanofi News
- 12 hours ago - South Korea's ADEL signs up to $1.04 billion Alzheimer's drug development deal with Sanofi - Reuters
- 16 hours ago - Sanofi: Today's Tolebrutinib Setback Shouldn't Worry Shareholders - This Is Why - Seeking Alpha
- 18 hours ago - Sanofi Expands Dren Bio Partnership With Potential $1.7 Billion Autoimmune Disease Collaboration - Benzinga
- 18 hours ago - Sanofi Expands Dren Bio Partnership With Potential $1.7 Billion Autoimmune Disease Collaboration - Benzinga
- 20 hours ago - Sanofi (SNY) Enters $1.7B Deal with Dren Bio for Antibody Therapies - GuruFocus
- 21 hours ago - Sanofi in deal worth up to $1.7B with Dren Bio for autoimmune disease treatments - Seeking Alpha
- 23 hours ago - Dren Bio to collaborate with Sanofi to develop autoimmune disease therapies for up to $1.7 billion - Reuters
- 23 hours ago - Dren Bio Expands Strategic Collaboration with Sanofi to Develop Next-Generation B-Cell Depletion Therapy - Business Wire